Predict your next investment

Venture Capital
FINANCIAL | Investment Firms & Funds
sevenpeaksventures.com

See what CB Insights has to offer

Investments

57

Portfolio Exits

10

Funds

5

About Seven Peaks Ventures

Seven Peaks Ventures is a venture capital firm based in Bend, Oregon and is focused on helping Oregon-based startups build and scale their businesses.

Seven Peaks Ventures Headquarter Location

1001 SW Emkay Drive Suite 140

Bend, Oregon, 97702,

United States

206-883-4451

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Seven Peaks Ventures Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Seven Peaks Ventures Rank

Latest Seven Peaks Ventures News

Care Automation Platform Bright.md Closes $16.7M Series C Round

May 28, 2020

What You Should Know: Bright.md closes oversubscribed $16.7 million Series Cfunding, co-led by B Capital, Seven Peaks Ventures and Concord Health Partners bringingin strategic investors including Philips Health Technology Ventures, UnityPointHealth Ventures and Concord Health Partners. Bright.md will use the funds to accelerate market andtechnology expansion of its suite of care-automation solutions, includingSmartExam. Bright.md ,the leading healthcare automation company, announced that it closed Series Cfunding, bringing in strategic investors including Philips Health Technology Ventures , UnityPointHealth Ventures and ConcordHealth Partners , a healthcare-focused investment firm that has partneredwith the American Hospital Association (AHA) on its AHA Innovation DevelopmentFund. Bright.md has raised $16.7 million in its oversubscribed Series C roundco-led by B Capital , Seven Peaks Ventures and Concord Health Partners . The Next Frontier in Healthcare Begins at the VirtualFront Door Co-founded in 2014 by Ray Costantini and MarkSwinth, Bright.md’s SmartExam acts as a virtual physician’s assistant –think of it as the best automated medical resident ever – that enables primarycare providers (PCPs) to deliver exceptionally efficient remote care for morethan 450 low-acuity conditions—the kinds of health issues that make up morethan 60% of primary- and urgent-care visits. The COVID-19 pandemic is shining a spotlight on the need for vibrant telehealth offerings. It has also exposed the limitations associated with video-only solutions. Though video has enabled patients and providers to continue care, video visits still require a scheduled appointment with a doctor, take weeks of provider training to become proficient, and take the same amount of physician time as in-person visits. Providers need to offer a virtual entry point to care, like Bright.md’s SmartExam, which streamlines care delivery across the entire care continuum. SmartExam is the first step along the care pathway. Bright.md’sAI-powered asynchronous virtual care platform enables patients to quickly sharetheir concerns and symptoms with providers, get a diagnosis and treatment, orbe fast-tracked for video, in-person, or specialty care. SmartExam acts like avirtual physician’s assistant, automating 90% of a primary, urgent care, orvideo visit, and reducing average visit time from 20 minutes to under 90seconds. By intelligently and automatically combining patient-intake data,interview information, electronic health records, and clinical-workflowintegration, then creating and entering SOAP notes and structured data into thepatient’s health record, SmartExam boosts provider efficiency 15x and increasesprovider capacity to treat hundreds of patients in a single provider shift. Recent Traction/Milestones Bright.md will use the funding for accelerated market andtechnology expansion of its suite of care-automation solutions, including theiraward-winning flagship product, SmartExam™, a capacity-boosting, AI-powered,asynchronous telehealth platform already deployed in leading hospitals andhealthcare systems across the U.S. and Canada. In the first three months of 2020, Bright.md’s healthcare delivery partners experienced more patient visits than during the 2019 calendar year and supported the evaluation of more than 100,000 COVID-related patient visits. The company currently works with some of the largest health systems to deliver treatment for nearly 500 conditions such as the flu, pediatrics, dermatology, muscular-skeletal, and behavioral health issues. Bright.md integrated coronavirus screening questions into its care platform in January and began offering a free screening tool to hospitals in early March. “Our new strategic investors share Bright.md’s vision to reimagine the way we deliver healthcare, especially in light of COVID-19,” said Ray Costantini, M.D., co-founder and CEO of Bright.md. “The pandemic has provoked a monumental shift in the care delivery and patient-provider experience. There’s no turning back. Healthcare will begin at the virtual front door, making healthcare delivery more efficient and allowing patients to get better care and providers to deliver it virtually and expeditiously. The capital and insight from our partners will enable us to achieve greater scale more rapidly in this next phase of our growth. We will be able to support more hospital systems in delivering patient navigation, triage, and treatment of low-acuity conditions, while seamlessly escalating those with more serious conditions to a higher level of care. We’ve worked toward this for six years, and I am extremely proud of what the team has accomplished and the high-value strategic partners our progress has attracted.” [ultimatesocial networks="facebook,twitter,google,linkedin,mail" url=""custom_class="us-posts-bottom" align="left" count="false"] Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Seven Peaks Ventures Investments

57 Investments

Seven Peaks Ventures has made 57 investments. Their latest investment was in Prime Trust as part of their Series A on July 7, 2021.

CBI Logo

Seven Peaks Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/28/2021

Series A

Prime Trust

$64M

Yes

Ayon Capital, Commerce Ventures, Diverse Angels, Kraken Ventures, Mercato Partners, Nationwide Ventures, Nevcaut Ventures, s20 Capital, Samsung NEXT, ST Capital, and University Growth Fund

2

6/30/2021

Series B

Virtuous

$18M

Yes

Fulcrum Equity Partners, Marketplace One, and MATH Venture Partners

5

6/21/2021

Seed VC

Ubco

$10M

Yes

Nuance Capital, and TPK Holding

1

4/7/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/18/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/28/2021

6/30/2021

6/21/2021

4/7/2021

2/18/2021

Round

Series A

Series B

Seed VC

Series A

Series C

Company

Prime Trust

Virtuous

Ubco

Subscribe to see more

Subscribe to see more

Amount

$64M

$18M

$10M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Ayon Capital, Commerce Ventures, Diverse Angels, Kraken Ventures, Mercato Partners, Nationwide Ventures, Nevcaut Ventures, s20 Capital, Samsung NEXT, ST Capital, and University Growth Fund

Fulcrum Equity Partners, Marketplace One, and MATH Venture Partners

Nuance Capital, and TPK Holding

Sources

2

5

1

10

10

Seven Peaks Ventures Portfolio Exits

10 Portfolio Exits

Seven Peaks Ventures has 10 portfolio exits. Their latest portfolio exit was Torch on December 10, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/10/2020

Acquired

3

8/11/2020

Acquired

2

8/5/2020

Acquired

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

12/10/2020

8/11/2020

8/5/2020

00/00/0000

00/00/0000

Exit

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

2

1

10

10

Seven Peaks Ventures Fund History

5 Fund Histories

Seven Peaks Ventures has 5 funds, including SPV I - CS II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/3/2020

SPV I - CS II

$0.27M

1

12/27/2018

SPV I - Amitree

Subscribe to see more

$99M

10

9/13/2018

Seven Peaks Ventures Fund II

Subscribe to see more

$99M

10

12/31/2013

Seven Peaks Ventures Fund I

Subscribe to see more

$99M

10

SPV I - CS

Subscribe to see more

$99M

10

Closing Date

1/3/2020

12/27/2018

9/13/2018

12/31/2013

Fund

SPV I - CS II

SPV I - Amitree

Seven Peaks Ventures Fund II

Seven Peaks Ventures Fund I

SPV I - CS

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$0.27M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Seven Peaks Ventures Team

4 Team Members

Seven Peaks Ventures has 4 team members, including current Investment Partner, Tom Gonser.

Name

Work History

Title

Status

Tom Gonser

Investment Partner

Current

J. Corey Schmid

Investment Partner

Current

Matt Abrams

General Partner

Former

Steven J Barham

LinkedIn, Mpower, Deluxe Corporation, Envestnet | Yodlee, and Riff

Investment Partner

Former

Name

Tom Gonser

J. Corey Schmid

Matt Abrams

Steven J Barham

Work History

LinkedIn, Mpower, Deluxe Corporation, Envestnet | Yodlee, and Riff

Title

Investment Partner

Investment Partner

General Partner

Investment Partner

Status

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.